The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial

• Jun-ichi Oyama ,

  * E-mail: junoyama@cc.saga-u.ac.jp (JO); node@cc.saga-u.ac.jp (KN)

  Affiliation Department of Cardiovascular Medicine, Saga University, Saga, Japan

  ⨯
• Toyoaki Murohara,

  Affiliation Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Masafumi Kitakaze,

  Affiliation Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center, Osaka, Japan

  ⨯
• Tomoko Ishizu,

  Affiliation Department of Clinical Laboratory Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

  ⨯
• Yasunori Sato,

  Affiliation Department of Global Clinical Research, Graduate School of Medicine, Chiba University, Chiba, Japan

  ⨯
• Kazuo Kitagawa,

  Affiliation Department of Neurology, Tokyo Women’s Medical University, Tokyo, Japan

  ⨯
• Haruo Kamiya,

  Affiliation Division of Cardiology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan

  ⨯
• Masayoshi Ajioka,

  Affiliation Department of Cardiovascular Internal Medicine, Tosei General Hospital, Seto, Japan

  ⨯
• Masaharu Ishihara,

  Affiliation Division of Cardiovascular Medicine and Coronary Heart Disease, Hyogo College of Medicine, Nishinomiya, Japan

  ⨯
• Kazuoki Dai,

  Affiliation Department of Cardiology, Hiroshima City Hospital, Hiroshima, Japan

  ⨯
• Mamoru Nanasato,

  Affiliation Cardiovascular Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan

  ⨯
• Masataka Sata,

  Affiliation Department of Cardiovascular Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

  ⨯
• Koji Maemura,

  Affiliation Department of Cardiovascular Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan

  ⨯
• Hirofumi Tomiyama,

  Affiliation Department of Cardiology, Tokyo Medical University, Tokyo, Japan

  ⨯
• Yukihito Higashi,

  Affiliation Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

  ⨯
• Kohei Kaku,

  Affiliation Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Japan

  ⨯
• Hirotsugu Yamada,

  Affiliation Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan

  http://orcid.org/0000-0003-3741-5560

  ⨯
• Munehide Matsuhisa,

  Affiliation Diabetes Therapeutics and Research Center, Tokushima University, Tokushima, Japan

  ⨯
• Kentaro Yamashita,

  Affiliation Department of Cardiology, Nagoya University Graduate School of Medicine and National Hospital Organization Nagoya Medical Center, Nagoya, Japan

  ⨯
• Yasuko K. Bando,

  Affiliation Department of Cardiology, Nagoya University Graduate School of Medicine and National Hospital Organization Nagoya Medical Center, Nagoya, Japan

  ⨯
• Naoki Kashihara,

  Affiliation Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan

  ⨯
• Shinichiro Ueda,

  Affiliation Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus, Nishihara, Japan

  ⨯
• Teruo Inoue,

  Affiliation Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan

  ⨯
• Atsushi Tanaka,

  Affiliation Department of Cardiovascular Medicine, Saga University, Saga, Japan

  ⨯
• Koichi Node ,

  * E-mail: junoyama@cc.saga-u.ac.jp (JO); node@cc.saga-u.ac.jp (KN)

  Affiliation Department of Cardiovascular Medicine, Saga University, Saga, Japan

  ⨯
•  [ ... ],
• PROLOGUE Study Investigators

  ¶A complete list of the PROLOGUE (Program of Vascular Evaluation under Glucose Control by DPP-4 Inhibitor) Study Investigators is provided in the Acknowledgments.

  ⨯
• [ view all ]
• [ view less ]